Tengonermin [CAS 1960461-99-7]

Tengonermin (ARENEGYR) is a vascular-targeting agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide. Tengonermin increases penetration of intratumoral chemotherapy and T-cell infiltration by modifying the tumour microenvironment[1][2].

[1960461-99-7]

[Tengonermin]

TNF Receptor

H2O

Room temperature